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Clinical interest for the identiﬁcation of the crystalline phase of CaOx, either monohydrate
(COM) or dihydrate (COD), in crystalluria analysis is debated. In the present study, we
simultaneously determined calcium and oxalate concentration and identiﬁed the two
crystalline phases of CaOx crystals in 1288 ﬁrst morning urine samples from 407 CaOx
stone formers with crystalluria.
The mean concentration of oxalate ions was higher in urine samples containing COM
than in those containing COD crystals, and conversely the mean concentration of calcium
ions was markedly higher in urine samples containing COD than in those containing COM
crystals. COM crystals were predominant (93%) in urine samples with a Ca/Ox molar ratio
<5 (i.e. with relative hyperoxaluria) whereas COD crystals were largely predominant
(98%) in urine samples with a Ca/Ox ratio >14 (i.e. markedly hypercalciuric). In the in-
termediate Ca/Ox values, mixed COD and COM crystals were present. Logistic regression
analysis showed that increasing the concentration of calcium resulted in a higher risk of
COD than of COM crystal formation, whereas increasing oxalate concentration was
associated with a greater COM than COD crystal formation. In conclusion, this study
demonstrates the calcium-dependence of COD and the oxalate-dependence of COM
crystal formation. Thus, a crystalluria mainly composed of COD suggests a search for
conditions associated with hypercalciuria whereas an abundant crystalluria made of COM
crystals should prompt a search for heavy hyperoxaluria and noteworthy primary
hyperoxaluria.
© 2016 Académie des sciences. Published by Elsevier Masson SAS. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).vice des Explorations
x 20, France.
Daudon).
ed by Elsevier Masson SAS.1. Introduction
Calcium oxalate (CaOx) calculi are presently the pre-
dominant type of urinary calculi throughout the world. In
France, they account for 75% of all calculi in men and 60% in
women. CaOx stones may contain one or several crystalline
forms among the three crystalline species of CaOx identi-
ﬁed in the urine of humans, namely calcium oxalateThis is an open access article under the CC BY-NC-ND license (http://
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drate (COD) or weddellite and, more scarcely, calcium ox-
alate trihydrate (COT) or caoxite. Although the
supersaturation level of CaOx is the well established major
factor that determines the propensity to form urinary CaOx
crystals [1], the respective inﬂuence of the urinary con-
centration of calcium (Ca) and oxalate (Ox) ions on the
crystalline phase of CaOx, either monohydrate or dihydrate,
is controversial [2e6].
In experimental models, the molar concentration of
oxalate was shown to have a greater inﬂuence on CaOx
crystallization than an equimolar calcium concentration
[7]. In our experience [8], the formation product of calcium
oxalate (FPCaOx) was decreasing with the CaOx molar
product (pCaOx) while oxalate concentration was increasing
and calcium concentration was decreasing, thus providing
evidence that the molar concentration of oxalate has a
greater effect than that of calcium on the CaOx crystalli-
zation. However, given the solubility product (Ksp) of CaOx
in water at 37 C, in the range of 2.2 to 3.6109 mol/L
[9,10], all urine samples appear dramatically supersatu-
rated and therefore should contain numerous CaOx crys-
tals, which is not the case. Indeed, in normal urine, the
average pCaOx value is around 6.107 (mmol/l)2 and no CaOx
crystal is found in most cases. Indeed, urine is a complex
medium containing numerous electrolytes including ions
able to interfere speciﬁcally with calcium or oxalate ions,
thus reducing the actual CaOx molar product and the CaOx
relative supersaturation. These ions are Mg2þ, citrate3,
HPO42, H2PO4, SO42, and P2O72, in various combina-
tions. In addition, according to the DebyeeHuckel equation,
the ionic strength of the medium, mainly related to the
content of Naþ, Kþ and Cl also contributes signiﬁcantly to
reduce CaOx supersaturation and thus to increase FPCaOx.
In healthy subjects, the average molar concentration of
urine calcium (range of 3mmol/l) is about ten times greater
than that of oxalate (range of 0.3 mmol/l) so that a pro-
portional increase of molar concentration for either oxalate
or calcium has a similar effect on calcium oxalate super-
saturation [11]. Moreover, in humans, a marked increase in
urinary calcium excretion without a concomitant increase
in oxalate excretion is frequent in stone formers with
idiopathic hypercalciuria, thus considerably increasing the
molar Ca/Ox ratio, whereas reciprocally a marked increase
in urinary oxalate concentration without a concomitant
increase in calcium concentration is only observed in some
pathological conditions, such as primary hyperoxaluria.
Thus, different values of the Ca/Ox ratio may be
observed within the same CaOx molar product (pCaOx),
resulting in the formation of distinct crystalline phases of
CaOx crystals [8]. Indeed, correlations between stone
composition and urinary parameters have shown that pa-
tients with hyperoxaluria preferentially form calculi made
of COM whereas those with hypercalciuria form calculi
mainly made of COD [12e14] and such was our experience
[8,15e17]. However, COM is the thermodynamically stable
form of CaOx, and so all other crystalline formsmay convert
into COM with time. This phenomenon was reported to be
fast for calcium oxalate trihydrate (COT), which is able to
convert into COM within a few minutes in vitro at 37 C
[18]. At variance with such experimental models, weoccasionally found calculi containing COT that had stayed
several months or years in the urinary tract. Regarding the
crystalline conversion from COD to COM in vivo, a number
of reports underline the frequent occurrence of crystalline
structures at the surface or within stones suggestive of
initial COD formation while polarized light microscopy,
infrared spectroscopy or X-ray analysis provide evidence of
a high COM content [9e22]. However, the kinetics of such a
crystalline conversion is poorly understood [23]. We have
incubated a pure COD stone within human urine at 37 C
for several months and failed to observe any trans-
formation of COD to COM (unpublished data). Therefore,
what are the biochemical conditions that favor in vivo the
primary formation of the various crystalline species of
CaOx in urine? It is a very important point from a clinical
point of view if we consider that around 60% of stones are
predominantly made of COMwhile 20e25% contain COD as
the main component. Because COT crystals are infrequent
in urine and calculi, we restricted our investigation to the
more common crystalline forms of CaOx, namely COM and
COD.
Therefore, we examined the relationship between uri-
nary concentrations of Ca and Ox and the type of CaOx
crystals, either COM or COD, in the same urine samples and
determined the effects of gradual increments in Ca and Ox
molar concentration on the respective risk of formation of
COM or COD crystals.
2. Materials and methods
We examined 1288 ﬁrst morning urine samples from
407 idiopathic calcium oxalate stone formers who had
CaOx crystalluria made up of either COM or COD. In every
sample, we determined the concentration of calcium and
oxalate. Morphologic identiﬁcation of urinary crystals was
made by polarization microscopy, as described elsewhere
[24].
In the ﬁrst part of the study, we determined in stone
formers the mean values of urinary Ca and Ox concentra-
tions in urine samples containing only either COM or COD
crystals, and reciprocally, we examined the type of crystals
with respect to the ratio of Ca to Ox concentration.
In the second part of the study, we examined by logistic
regression analysis the effects of increasing concentrations
of Ca or Ox above the average values observed in ﬁrst
morning urine samples from 227 healthy subjects. Among
267 healthy controls in our database, 40 (15%) exhibited
calcium oxalate crystals in their urine. COD crystals
accounted for 92.5% of cases and COM crystals were found
in only 2.6% of urine samples (7.5% of samples containing
calcium oxalate crystals). Mean calcium and oxalate values
found in these samples were very similar to the respective
values observed in urine samples of stone formers with
calcium oxalate crystals (data no shown). So, we retained
227 urine samples from healthy controls without calcium
oxalate crystals. The mean value for calcium and oxalate
concentration was 3.31± 2.14 mmol/l and
0.35± 0.17 mmol/l, respectively, taken as reference values
(relative risk 1) in the absence of COM or COD crystalluria.
In the last part of the study, we examined the presence
of calcium oxalate crystalluria in relationwith pCaOx and the
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Fig. 1. Inﬂuence of urine oxalate concentration on the occurrence of calcium
oxalate crystals in kidney stone formers.
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designed a nomogram for calcium oxalate crystallization
based on the microscopic examination of 30,250 urine
samples from stone formers.
All statistical comparisons regarding biochemistry of
urine with or without crystals (ANOVA), the distribution of
crystalline phases according to rCaOx (Chi2 test) and logistic
regression analyses to assess the relative risk of forming
either COM or COD crystals were performed with the NCSS
statistical package (J. Hintz, Gainesville, FL, USA). A p value
less than 0.05 was considered as statistically signiﬁcant.
3. Results
Biochemical data for each group are summarized in
Table 1.
The mean concentration of oxalate ions was higher in
urine samples containing pure COM crystals than in those
containing pure COD crystals (0.58± 0.43 vs
0.38± 0.18 mmol/l, p < 0.0001) whereas conversely the
mean concentration of calcium ions was markedly higher
in urine samples purely containing COD than in those
containing COM crystals (7.34± 3.11 vs 2.32± 1.98 mmol/l,
p < 0.0001). Of note, in urine samples containing pure COD
crystals, oxalate concentration did not differ from themean
value found in healthy controls whereas calcium concen-
tration was more than twofold higher than in healthy
subjects.
As shown in Fig. 1, the proportion of urine samples
exhibiting CaOx crystals is increasing in parallel with oxa-
late concentration, with an inﬂexion point around
0.3 mmol/l, more precisely 0.31 mmol/l. Above this
threshold, more than 43% of all samples contained crystals,
whereas below this value less than 22% of samples
exhibited CaOx crystals.
With respect to calcium concentration (Fig. 2), an
inﬂexion point was found around 3.8 mmol/l. More than
40% of urine samples contained CaOx crystals for calcium
concentrations above this threshold versus less than 18%
below this value.Table 1
Biochemical data in urine of stone formers and healthy subjects.
Calcium oxalate
stone formers
Healthy subjects
Solutes Urine samples
with COM
crystals
Urine samples
with COD
crystals
Urine samples
without crystals
No of samples 363 925 227
Calcium 2.32± 1.98***,  7.34± 3.11 3.31± 2.14
Oxalate 0.58± 0.43***,  0.38± 0.18 0.35± 0.17
Phosphate 22.72± 16.27*** 30.84± 14.36 26.95± 17.1
Urate 2.27± 1.48***,  3.03± 1.21 2.76± 1.34
Citrate 1.48± 1.42***,  2.33± 1.64 2.32± 1.74
Magnesium 2.90± 2.38***,  4.78± 2.11 3.63± 1.34
Sodium 82± 45***,  99± 42 108± 55
Potassium 35± 23 34± 17 41± 26
Chloride 78± 49 85± 42 90± 51
Urea 268± 154***,  356± 112 315± 141
Creatinine 9,26± 6.39***,  14.08± 5.37 12.61± 6.67
** p < 0.001, *** p < 0.0001 versus urine samples with COD crystals.
 p < 0.001,  p < 0.0001 versus control urine samples without crystals.Of note, neither high oxalate concentration nor high
calcium concentration alone is able to induce CaOx crystal
formation in 100% of urine samples. As expected, the main
driving force for CaOx crystallization is pCaOx. The occur-
rence of CaOx crystalluria increased up to 100% of urine
samples for pCaOx values above 4.5 (mmol/l)2 in stone for-
mers, and healthy controls as well (Fig. 3).
Interestingly, when comparing urine samples from
stone formers and healthy subjects, signiﬁcant differ-
ences were found regarding the occurrence of CaOx
crystalluria for most values of pCaOx ranging from 0.5 to 4
(mmol/l)2. The frequency of CaOx crystalluria was lower
in healthy subjects than in stone formers for any pCaOx
value below 4.5 (mmol/l)2, thus suggesting an imbalance
between promoters and inhibitors of crystallization or a
defect of inhibitors in stone formers conversely to
healthy subjects.
The molar calcium/oxalate ratio (rCaOx) seems to be an
important factor determining the crystalline phase of CaOx.
Low values of the rCaOx ratio are associated with higher
frequency of COM crystalluria, whereas conversely high0
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Fig. 2. Inﬂuence of urine calcium concentration on the occurrence of cal-
cium oxalate crystals in kidney stone formers.
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shown in Fig. 4, COM crystals were predominant (93%) in
urine samples with a rCaOx < 5 (i.e. with relative hyper-
oxaluria), either as pure COM crystals (64%) or COM mixed
with COD crystals (29%). Conversely, COD crystals were
largely predominant (98%), mainly as pure COD crystals
(87%), in urine samples with a rCaOx > 14 (i.e. markedly
hypercalciuric). In the intermediate Ca/Ox values, COD
crystals accounted for 84%, either pure (51%) or mixed with
COM (33%). The data were collected from 6869 urine
samples that contained calcium oxalate crystals identiﬁed
by polarizing microscopy.
Fig. 5 shows the effect of graded increments in cal-
cium and oxalate concentration above a basal level
(3.3 mmol/l for calcium, 0.35 mmol/l for oxalate: relative
risk¼1) on the relative risk of forming COM and COD
crystals in urine. The inﬂuence of increasing solute con-
centrations was especially marked for the highest values
of calcium and oxalate. A 100% (twofold) increase in
calcium concentration was associated with a 35 times
higher risk of COD crystal formation (Fig. 5B), but only a 4
times higher risk of COM crystal formation (Fig. 5A).64
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Fig. 4. Inﬂuence of the molar calcium/oxalate ratio (rCaOx) on the crystalline
phases of CaOx observed in urine. Data collected from 6869 urine samples
that contained calcium oxalate crystals. *** p < 0.00001 versus 5  rCaOx < 14
and versus rCaOx > 14. xx p < 0.001 versus 5  rCaOx < 14.Conversely, a twofold increase in oxalate concentration
was associated with a 38 times higher risk of COM crystal
formation (Fig. 5A), but with only a 4 times higher risk of
COD crystal formation (Fig. 5B).
The risk of stone formation is closely related to the
occurrence of crystals in urine. In a prospective clinical
study, we found that presence of crystals in more than 50%
of ﬁrst morning urine samples in a given patient was
associated with stone recurrence in 88% of cases in the
absence of speciﬁc preventive measures [25]. However,
each patient has a peculiar urine proﬁle depending on the
balance between promoters and inhibitors of crystalliza-
tion, including unmeasured macromolecules. As a result,
certain patients are more sensitive to the effects of
increasing calcium whereas other subjects are more sen-
sitive to the effect of increasing oxalate at the risk of CaOx
crystal formation.
In order to assess the individual risk of CaOx crystal
formation, we developed a nomogram based on the
microscopic examination of more than 30,000 urine
samples. Calcium and oxalate were determined in each
sample as well as the presence and the crystalline form of
CaOx crystals. The nomogram was constructed in loga-
rithmic scale. The ordinate was the rCaOx while the abscissa
was pCaOx. Thus, calcium concentration was increasing and
conversely oxalate concentration was decreasing from the
bottom to the top of the vertical axis, whereas the pCaOx
value was increasing from the left to the right part of theOxalate (RR) Calcium (RR)
0       10      20       30       40      50       60      70      80       90     100
0
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Fig. 5. Relative inﬂuence of calcium and oxalate concentration on the
relative risk to form COM (Fig. 5A) and COD (Fig. 5B) crystals in the urine of
stone formers.
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oxalate and 3.8 mmol/l for calcium were used to illustrate
areas corresponding to four possible conditions (Fig. 6):
- normal area with calcium <3.8 mmol/l and oxalate
<0.31 mmol/l.
- hypercalciuria area with calcium 3.8 mmol/l and
oxalate <0.31 mmol/l.
- hyperoxaluria area with oxalate 0.31 mmol/l and
calcium <3.8 mmol/l.
- both hyperoxaluria and hypercalciuria area with oxa-
late 0.31 mmol/l and calcium 3.8 mmol/l.
According to various levels for rCaOx and pCaOx values,
we divided the nomogram into quadrants and we deter-
mined the global frequency of CaOx crystalluria for each
quadrant. The score for the observed crystalluria was
established as described in Table 2.
Finally, to allow an easy graphic use of the nomogram,
we reported calcium and oxalate scales allowing to join by a
straight line the points corresponding to the same value on
the two scales. Thus, the urine point corresponding to given
values for calcium and oxalate corresponds to a quadrant
affected of a crystallization score. Based on the previous
prospective study of stone recurrence in calcium stone for-
mers, we established a predictive clinical risk of stone for-
mation. Thus, all crystallization score values from 4 to 7Table 2
Crystallization score related to the frequency of CaOx crystalluria (fc).
Frequency (%) of
CaOx crystalluria
Crystallization
score
Clinical risk of
stone formation
0 < fc  10 1 very low
10 < fc  25 2 low
25 < fc  40 3 medium
40 < fc  60 4 moderately increased
60 < fc  75 5 high
75 < fc  90 6 very high
90 < fc  100 7 maximum
rCaOx
pCaOx
3,8 mmol/l
of calcium
1.15
12,5
0,31 mmol/l
of oxalate
HYPERCALCIURIA
NORMAL
AREA
HYPEROXALURIA
HYPERCALCIURIA
+
HYPEROXALURIA
calcium
oxalate
(mmol/l)
Fig. 6. Schematic representation of the different areas on the calcium oxa-
late crystallization nomogram according to calcium and oxalate concentra-
tions in the urine of stone former patients.suggest an increased risk of stone formation, the maximum
(score 7) corresponding to quadrants where more than 90%
of the urine samples contain CaOx crystals. The resulting
nomogram is shown in Fig. 7. Our data suggest that urine
samples with a pCaOx value above 2 (mmol/l)2 are more at
risk of favoring stone recurrence than urine samples with a
pCaOx below this threshold. As expected, urine samples with
a low pCaOx (<1 (mmol/l)2) are associated with the lowest
risk of crystallization. Thus, the clinical objective is to reduce
pCaOx by dietary measures and increased diuresis. Note that
the ellipsoid area gathers together around 50% of all urine
samples from stone formers.
When all urine samples of a patient are reported in the
nomogram, different situations can be observed, reﬂect-
ing the own urine balance between promoters and in-
hibitors of the patient. Such ﬁnding may be clinically
relevant for managing preventive measures in order to
avoid or delay stone recurrence. Some examples are given
in Figs. 8 and 9.
In Fig. 8, all urine samples examined for a given patient
over a ﬁve year period clearly provide evidence that the
presence of CaOx crystals (þ) was mainly dependent on the
calcium concentration since no crystal was observed when
urine calcium was below 4.75 mmol/l. By contrast, crys-
talluria was negative () for relatively high oxalate con-
centrations (0.55 mmol/l).
Fig. 9 illustrates another situation. All urine samples
where oxalate concentration was higher than 0.26 mmol/l
contained CaOx crystals, even when calcium concentration
was normal (3.2 mmol/l). By contrast, none of the samples
below this threshold exhibited CaOx crystals despite a high
calcium concentration (up to 13 mmol/l) in several cases.
Obviously, this patient was more sensitive to oxalate than
to calcium concentration.
4. Discussion
Our data show that the formation of urinary COD
crystals is predominantly associated with a high urinary
calcium concentration, whereas formation of COM crys-
tals is predominantly associated with a high oxalate
concentration, thus supporting the concept of calcium-
dependence of COD and of oxalate-dependence of COM.
The present study conﬁrms and extends our previous
ﬁndings on the association of hypercalciuria with COD
stones and crystals, and of hyperoxaluria with COM stones
and crystals [17,26,27].
Concordant observations were reported by other groups
with respect to both calcium dependence of COD and ox-
alate dependence of COM.
4.1. Calcium-dependence of COD
Conte et al. [12], examining the relationship between the
type of calcium oxalate hydrate present in renal calculi and
urinary biochemistry parameters, observed an association
between hypercalciuria and COD calculi. Pierratos et al. [13]
showed that 422 patientswith pure COM stones had a lower
urinary calcium excretion (4.2 mmol/day) compared to 68
patients with pure COD stones (7.2 mmol/day). Asplin et al.
[14], examining metabolic correlates of CaOx dihydrate in
Fig. 7. Calcium oxalate crystallization nomogram with crystallization score values.
M. Daudon et al. / C. R. Chimie 19 (2016) 1504e1513 1509renal stones, reported that patients with COD in their stones
had higher urinary calcium excretion than those without.
In vitro, Costa-Bauza et al. [28] analyzed various uri-
nary conditions affecting the regrowth of COD stone re-
sidual fragments from patients treated by ESWL. Marked
hypercalciuria (6.25 mmol/l) associated with a urine pH of
6.5 was associated with the formation of COD crystals and
regrowth of residual stone fragments, whereas in the
presence of normocalciuria (3.75 mmol/l) and relativelyacidic urine (pH 5.5) only some COM crystals were
detected. Thongboonkerd et al. [29] analyzed the inﬂu-
ence of different concentrations of calcium and oxalate
ions on the type of CaOx crystals formed. In the presence
of 0.5e1 mmol/l CaCl2 (a low calcium concentration) and
0.5e1 mmol/l NaOx (a high oxalate concentration), typical
monoclinic prismatic COM crystals formed. In contrast, in
the presence of 5 mmol/l CaCl2 (a high calcium concen-
tration) and 0.5 mmol/l NaOx (a moderately elevated
Fig. 8. Example of a calcium-dependent risk of CaOx crystallization in urine.
M. Daudon et al. / C. R. Chimie 19 (2016) 1504e15131510oxalate concentration), COD crystals preferentially
appeared.
Taken together, all published studies conclude to the
calcium-dependence of COD stones and crystals.
Of note, a marked dependence on hypercalciuria
(together with a urinary pH slightly over 6) has also been
observed for stones composed of brushite, at variance with
other calcium phosphates types, which rather depend on
elevated urinary pH and phosphate excretion [30,31]. Highurinary calcium excretion and pH around 6 are also found
in stone-forming patients with primary hyperthyroidism
[32], who exhibit a disproportionate high prevalence of
brushite stones [33].
4.2. Oxalate-dependence of COM
Oxalate-dependence of COM crystal formation was
shown in two of the above-mentioned studies [13,29] but is
Fig. 9. Example of an oxalate-dependent risk of CaOx crystallization in urine.
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papers dealing with spontaneous crystalluria in stone
former patients. Indeed, most authors usually refer to CaOx
in crystals or stones as a single entity, without mentioning
the type of hydrate form. However, our study unequivocally
shows that COM crystals are associated with a high oxalate
concentration facing a normal or low-normal calcium
concentration and that hyperoxaluria electively favors the
precipitation of COM crystals.Primary hyperoxalurias (PH) represent the extreme of
heavy hyperoxaluria, and are associated with the presence
of abundant crystalluria mainly composed of COM crystals
and with the formation of calculi totally or nearly totally
made of COM [34e36]. Indeed, this pathognomonic
composition related to hyperoxaluria was conﬁrmed in our
experience in a total of 124 patients affected with PH1, but
more rarely in PH2 or PH3, two forms of less severe
hyperoxaluria. COM was identiﬁed as the unique crystal
M. Daudon et al. / C. R. Chimie 19 (2016) 1504e15131512phase both in 72 calculi found at presentation and in 24
stones passed while on treatment. COD crystals were
associatedwith COM in a small proportion of the stones (7%
in PH1), at variance with ﬁndings recently reported in a
short series of 16 patients (10 PH1, 6 PH3) including pre-
sumably only naïve stones [37]. In our experience, such
mixtures of COM and COD in stones were mainly found in
PH2 and PH3, not in PH1 patients. Most calculi in our PH
patients exhibited a peculiar morphology [35,38]. Their
composition was identiﬁed as COM by FTIR and SEM
showed exclusively COM crystals in most cases. In our se-
ries, stones with a partially resembling morphology and
also mainly made of COM were found in patients with
enteric hyperoxaluria due to inﬂammatory bowel diseases
or following bariatric surgery, both conditions often asso-
ciating heavy oxaluria and low calciuria [39].
4.3. Theoretical and clinical relevance of the distinction
between COM and COD crystalluria
The calcium-dependence of COD and the oxalate-
dependence of COM crystals reﬂect differences in the
physico-chemical factors leading to the formation of these
two types of CaOx crystals [6]. Besides its theoretical in-
terest, the distinction between COMand COD in crystalluria
studies has similar clinical relevance, as the distinction
performed on stones themselves, in order to ﬁnd theFig. 10. a) Mixed crystalluria of octahedral COD (white arrow) and oval COM crystal
hypercalciuria. c) Large octahedral crystals of COD highly suggestive for both hypeetiology of renal stone disease, especially when no stone is
available for analysis [40,41].
A crystalluria showing predominantly COM crystals is
indicative of a lithogenic process driven by a high oxalate
concentration. Especially, the presence of abundant COM
crystalluria (>200 COM crystals/mm3) is observed in the
context of heavy hyperoxaluria and should prompt a search
for primary hyperoxaluria [42]. Finding of COD crystals is of
less speciﬁc diagnostic value, but consistently is associated
with a high calcium concentration. However, the presence
of COD crystals with a dodecahedral aspect (Fig. 10) is
indicative of a high calcium concentration, usually in excess
of 7 mmol/l, as observed in severe forms of idiopathic
hypercalciuria [43]. Similarly, the presence of large crystals
of COD (size >25 mm) with an octahedral aspect, as shown
in Fig. 10c, may be clinically relevant because such crystals
are indicative of both hyperoxaluria and hypercalciuria
with a Ca/Ox ratio usually in the normal range, i.e. between
5 and 14.
In conclusion, this study demonstrates that the forma-
tion of urinary COD crystals is predominantly associated
with a high urinary calcium concentration, whereas for-
mation of COM crystals is predominantly associated with a
high oxalate concentration. Increasing calcium concentra-
tion is associated with a higher prevalence of COD than of
COM crystal formation, whereas increase in oxalate con-
centration is associated with a greater COM than CODs. b) Dodecahedral crystal of COD as observed commonly in the case of heavy
rcalciuria and hyperoxaluria.
M. Daudon et al. / C. R. Chimie 19 (2016) 1504e1513 1513crystal formation. Thus, a crystalluria mostly made of COM
orients to a condition associated with hyperoxaluria,
whereas predominance of COD crystals orients towards
hypercalciuria.
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